Vaxcyte IncNASDAQ:PCVX
- LAST PRICE49.7100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots19.9000/ 2
- Ask / Lots54.9000/ 2
- Open / Previous Close50.3800 / 49.7100
- Day Range
- 52 Week Range
- Volume502,591
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PCVX |
|---|---|---|
| 09:32 ET | 13216 | 51.1 |
| 09:33 ET | 9000 | 50.6701 |
| 09:35 ET | 414 | 51.12 |
| 09:39 ET | 1340 | 51.03 |
| 09:42 ET | 2225 | 51.095 |
| 09:44 ET | 11159 | 50.475 |
| 09:50 ET | 356 | 50.65 |
| 09:51 ET | 800 | 50.64 |
| 09:53 ET | 100 | 50.53 |
| 09:55 ET | 5116 | 51.1 |
| 09:57 ET | 100 | 50.96 |
| 10:00 ET | 300 | 51.055 |
| 10:02 ET | 979 | 51.16 |
| 10:04 ET | 300 | 50.915 |
| 10:08 ET | 801 | 50.8271 |
| 10:09 ET | 1200 | 50.72 |
| 10:11 ET | 200 | 50.765 |
| 10:13 ET | 132 | 50.77 |
| 10:18 ET | 200 | 50.77 |
| 10:20 ET | 300 | 50.66 |
| 10:24 ET | 700 | 50.75 |
| 10:26 ET | 343 | 50.725 |
| 10:27 ET | 532 | 50.885 |
| 10:29 ET | 2597 | 50.98 |
| 10:31 ET | 1609 | 50.895 |
| 10:33 ET | 100 | 50.94 |
| 10:36 ET | 600 | 50.9 |
| 10:38 ET | 402 | 50.925 |
| 10:40 ET | 530 | 50.915 |
| 10:42 ET | 100 | 50.94 |
| 10:44 ET | 400 | 50.98 |
| 10:45 ET | 2452 | 50.985 |
| 10:47 ET | 600 | 50.975 |
| 10:49 ET | 1838 | 50.71 |
| 10:54 ET | 534 | 50.86 |
| 10:56 ET | 100 | 50.8 |
| 10:58 ET | 443 | 50.73 |
| 11:00 ET | 1201 | 50.66 |
| 11:02 ET | 500 | 50.73 |
| 11:05 ET | 800 | 50.745 |
| 11:07 ET | 300 | 50.69 |
| 11:09 ET | 200 | 50.735 |
| 11:12 ET | 2704 | 50.695 |
| 11:14 ET | 1400 | 50.53 |
| 11:16 ET | 768 | 50.545 |
| 11:18 ET | 100 | 50.54 |
| 11:20 ET | 100 | 50.44 |
| 11:21 ET | 100 | 50.53 |
| 11:23 ET | 100 | 50.44 |
| 11:27 ET | 200 | 50.573 |
| 11:30 ET | 300 | 50.525 |
| 11:32 ET | 967 | 50.68 |
| 11:34 ET | 2535 | 50.78 |
| 11:36 ET | 359 | 50.78 |
| 11:38 ET | 5873 | 51 |
| 11:39 ET | 600 | 50.84 |
| 11:41 ET | 100 | 50.77 |
| 11:43 ET | 700 | 50.79 |
| 11:50 ET | 200 | 50.735 |
| 11:52 ET | 208 | 50.63 |
| 11:56 ET | 300 | 50.66 |
| 11:57 ET | 100 | 50.645 |
| 11:59 ET | 100 | 50.62 |
| 12:01 ET | 100 | 50.61 |
| 12:06 ET | 400 | 50.48 |
| 12:08 ET | 300 | 50.51 |
| 12:15 ET | 100 | 50.5 |
| 12:17 ET | 300 | 50.58 |
| 12:21 ET | 400 | 50.46 |
| 12:26 ET | 300 | 50.485 |
| 12:28 ET | 100 | 50.56 |
| 12:30 ET | 400 | 50.415 |
| 12:32 ET | 700 | 50.41 |
| 12:33 ET | 450 | 50.435 |
| 12:35 ET | 500 | 50.38 |
| 12:37 ET | 227 | 50.44 |
| 12:39 ET | 816 | 50.45 |
| 12:42 ET | 618 | 50.42 |
| 12:46 ET | 100 | 50.51 |
| 12:50 ET | 520 | 50.5 |
| 12:51 ET | 700 | 50.47 |
| 12:53 ET | 200 | 50.51 |
| 12:55 ET | 21000 | 50.51 |
| 12:57 ET | 40170 | 50.31 |
| 01:00 ET | 1027 | 50.495 |
| 01:02 ET | 100 | 50.44 |
| 01:04 ET | 200 | 50.445 |
| 01:09 ET | 1400 | 50.39 |
| 01:11 ET | 100 | 50.39 |
| 01:13 ET | 100 | 50.46 |
| 01:15 ET | 420 | 50.405 |
| 01:18 ET | 1465 | 50.49 |
| 01:22 ET | 100 | 50.45 |
| 01:24 ET | 1100 | 50.5 |
| 01:29 ET | 400 | 50.39 |
| 01:31 ET | 710 | 50.44 |
| 01:33 ET | 300 | 50.375 |
| 01:36 ET | 200 | 50.43 |
| 01:38 ET | 100 | 50.473 |
| 01:40 ET | 100 | 50.48 |
| 01:42 ET | 100 | 50.465 |
| 01:45 ET | 100 | 50.455 |
| 01:47 ET | 300 | 50.44 |
| 01:49 ET | 413 | 50.5 |
| 01:51 ET | 406 | 50.51 |
| 01:56 ET | 100 | 50.54 |
| 02:00 ET | 300 | 50.5 |
| 02:03 ET | 1100 | 50.54 |
| 02:07 ET | 1041 | 50.5 |
| 02:09 ET | 1316 | 50.46 |
| 02:12 ET | 1000 | 50.52 |
| 02:16 ET | 100 | 50.445 |
| 02:18 ET | 100 | 50.505 |
| 02:20 ET | 200 | 50.51 |
| 02:21 ET | 300 | 50.58 |
| 02:23 ET | 160 | 50.515 |
| 02:25 ET | 600 | 50.515 |
| 02:30 ET | 1031 | 50.44 |
| 02:32 ET | 406 | 50.44 |
| 02:34 ET | 540 | 50.41 |
| 02:36 ET | 300 | 50.4 |
| 02:38 ET | 800 | 50.225 |
| 02:41 ET | 500 | 50.235 |
| 02:43 ET | 100 | 50.195 |
| 02:45 ET | 300 | 50.23 |
| 02:48 ET | 100 | 50.175 |
| 02:52 ET | 1983 | 50.2 |
| 02:54 ET | 300 | 50.135 |
| 02:56 ET | 1258 | 50.1125 |
| 02:57 ET | 100 | 50.125 |
| 02:59 ET | 100 | 50.08 |
| 03:01 ET | 1500 | 49.995 |
| 03:08 ET | 1726 | 49.91 |
| 03:10 ET | 917 | 50.01 |
| 03:12 ET | 881 | 50.145 |
| 03:14 ET | 600 | 50.085 |
| 03:17 ET | 800 | 50.06 |
| 03:19 ET | 100 | 50.04 |
| 03:21 ET | 1215 | 50.09 |
| 03:24 ET | 1700 | 50.0775 |
| 03:26 ET | 100 | 50.065 |
| 03:28 ET | 100 | 50.01 |
| 03:30 ET | 300 | 50.07 |
| 03:32 ET | 600 | 50.09 |
| 03:33 ET | 854 | 50.025 |
| 03:35 ET | 703 | 50.04 |
| 03:37 ET | 807 | 49.82 |
| 03:39 ET | 557 | 49.777 |
| 03:42 ET | 1300 | 49.77 |
| 03:44 ET | 204 | 49.78 |
| 03:46 ET | 1373 | 49.72 |
| 03:48 ET | 916 | 49.66 |
| 03:50 ET | 957 | 49.6325 |
| 03:51 ET | 1295 | 49.58 |
| 03:53 ET | 1655 | 49.675 |
| 03:55 ET | 2532 | 49.765 |
| 03:57 ET | 7283 | 49.71 |
| 04:00 ET | 115823 | 49.71 |
Nov 28, 2023
Vaxcyte Appoints Jacks Lee to Board of Directors, from 8:30AM ET on Tuesday Nov 28, 2023 by Dow Jones
8:30AM ET on Tuesday Nov 28, 2023 by Dow JonesPress Release: Vaxcyte Appoints Jacks Lee to Board of Directors, from 8:30AM ET on Tuesday Nov 28, 2023 by Dow Jones
8:30AM ET on Tuesday Nov 28, 2023 by Dow Jones
Nov 27, 2023
DJ Vaxcyte Exercises Right to Manufacture Sutro Biopharma's Cell-Free Extract, from 4:18PM ET on Monday Nov 27, 2023 by Dow Jones
4:18PM ET on Monday Nov 27, 2023 by Dow JonesVaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates, from 4:00PM ET on Monday Nov 27, 2023 by Dow Jones
4:00PM ET on Monday Nov 27, 2023 by Dow Jones
Nov 9, 2023
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vaxcyte Inc | 4.7B | -15.1x | --- |
Cerevel Therapeutics Holdings Inc | 4.6B | -10.1x | --- |
BridgeBio Pharma Inc | 5.0B | -7.3x | --- |
CRISPR Therapeutics AG | 5.5B | -15.4x | --- |
Mirati Therapeutics Inc | 4.0B | -4.7x | --- |
Immunovant Inc | 5.5B | -19.5x | --- |
Company Information
Vaxcyte Inc. is a clinical-stage vaccine company. The Company develops conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its synthetic techniques include advanced chemistry and the XpressCF cell-free protein synthesis platform, licensed from Sutro Biopharma, Inc., or Sutro Biopharma. Its pipeline includes Pneumococcal conjugate vaccine (PCV), VAX-A1, VAX-PG and VAX-GI. Its lead vaccine candidate, VAX-24, is a 24-valent investigational PCV being developed for the prevention of invasive pneumococcal disease (IPD). Its second PCV candidate, VAX-31, is designed to prevent IPD. population. VAX- 24 is intended to improve upon the standard-of-care PCV vaccines for both children and adults. VAX-A1 is a conjugate vaccine candidate designed to prevent disease caused by Group A Streptococcus or Group A Strep. VAX-PG is a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis. VAX-GI is a vaccine program designed to prevent Shigella.
Contact Information
- Headquarters
- 825 INDUSTRIAL ROAD, STE. 300SAN CARLOS, CA, United States 94070
- Phone
- 650-837-0111
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Carlos Paya
- Chief Financial Officer
- Andrew Guggenhime
- Chief Executive Officer, Co-Founder, Director
- Grant Pickering
- Chief Operating Officer, Executive Vice President
- James Wassil
- Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary
- Mikhail Eydelman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.7B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 95.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.85 |
EPS | $-3.30 |
Book Value | $12.00 |
P/E Ratio | -15.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
